Apr 26, 2018 12:01 pm UTC| Business
OXNARD, Calif., April 26, 2018 -- CDTi Advanced Materials, Inc., (Nasdaq:CDTI) (“CDTi” or “the Company”), a leader in advanced emission control technology, announced it is partnering with a consortium led by University...
Rexahn to Present Clinical Data at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
Apr 26, 2018 12:01 pm UTC| Business
Preliminary Safety and Efficacy Data from Phase 1b/2a Trial of RX-5902 in Advanced Triple Negative Breast Cancer Updated Safety and Efficacy Data on RX-3117 in Advanced Urothelial (Bladder) Cancer ROCKVILLE, Md., April ...
CTS Announces First Quarter 2018 Results
Apr 26, 2018 12:01 pm UTC| Business
LISLE, Ill., April 26, 2018 -- CTS Corporation (NYSE:CTS) today announced first quarter 2018 results. Sales were $113.5 million, up 13.4% year-over-year. Sales to automotive customers increased 11.9%, and sales of...
Synaptics Second-Generation USB Type-C Headset SoCs in Mass Production with Major Smartphone OEM
Apr 26, 2018 12:01 pm UTC| Business
SAN JOSE, Calif., April 26, 2018 -- Synaptics Incorporated (NASDAQ:SYNA), the leading developer of human interface solutions, today announced its second-generation AudioSmart® digital headset SoC solution for USB Type-C...
Apr 26, 2018 12:01 pm UTC| Business
BOULDER, Colo., April 26, 2018 -- FreeWave Technologies, a leader in industrial, secure Machine-to-Machine (M2M) and Industrial Internet of Things (IIoT) networking solutions, today announced a technology partnership...
IsoRay Announces Third Quarter Fiscal 2018 Earnings Conference Call
Apr 26, 2018 12:01 pm UTC| Business
RICHLAND, Wash., April 26, 2018 -- IsoRay, Inc. (the “Company”) (NYSE American: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate,...
Apr 26, 2018 12:01 pm UTC| Business
Phase 1/2 clinical trial in patients with Parkinson's disease (PD) expanded to add additional cohort. NEW YORK, April 26, 2018 -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on...